Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
Kumar, V.P., Cisneros, J.A., Frey, K.M., Castellanos-Gonzalez, A., Wang, Y., Gangjee, A., White, A.C., Jorgensen, W.L., Anderson, K.S.(2014) Bioorg Med Chem Lett 24: 4158-4161
- PubMed: 25127103 
- DOI: 10.1016/j.bmcl.2014.07.049
- Primary Citation of Related Structures:  
4Q0D, 4Q0E - PubMed Abstract: 
Cryptosporidium is the causative agent of a gastrointestinal disease, cryptosporidiosis, which is often fatal in immunocompromised individuals and children. Thymidylate synthase (TS) and dihydrofolate reductase (DHFR) are essential enzymes in the folate biosynthesis pathway and are well established as drug targets in cancer, bacterial infections, and malaria ...